Safety, Tolerability and PK/PD of SHR1459 in Healthy Volunteers

Summary

This was a phase I, single-center, double-blind, randomized, placebo-controlled study to assess the safety, tolerability and pharmacokinetics/pharmacodynamics of the investigational medicinal product in healthy volunteers.

Timeline

Start

2018-09-01

Primary completion

2019-01-01

Completion

2019-03-01

Drugs

Indications

No indication recorded.